Skip to main content
OpenTrials

Clinical trial condition

Hemostatic Disorders

Explore clinical trials studying Hemostatic Disorders. Study availability and eligibility vary by location and protocol.

3,079 public trials 581 recruiting studies
Refine in advanced search Browse all conditions

Hemostatic Disorders trial results

Completed

A Phase 2 Study of Lenalidomide to Evaluate the Efficacy in Japanese Patients With Newly Diagnosed Multiple Myeloma

NCT01698801

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Nagoya Daini Red Cross Hospital Nagoya, Aichi-ken, Japan
  • Nagoya City University Hospital Nagoya, Aichi-ken, Japan
  • Kameda Medical Center Kamogawa, Chiba, Japan
  • Japanese Red Cross Narita Hospital Narita, Chiba, Japan
View all 24 locations
View Trial Details
Completed

Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement

NCT00869206

Conditions
Blood Protein Disorders, Breast Adenocarcinoma, Breast Diseases, +35 more
Locations
  • Fairbanks Cancer Treatment Center at Fairbanks Memorial Hospital Fairbanks, Alaska, United States
  • Mayo Clinic Scottsdale Scottsdale, Arizona, United States
  • East Bay Radiation Oncology Center Castro Valley, California, United States
  • Valley Medical Oncology Consultants - Castro Valley Castro Valley, California, United States
View all 504 locations
View Trial Details
Completed

Lenalidomide/Bortezomib/Dexamethasone for Multiple Myeloma (MM)

NCT01782963

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • John Hopkins University Baltimore, Maryland, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Brigham and Women's Hospital Boston, Massachusetts, United States
View Trial Details
Completed

A Phase 3, Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Pomalidomide in Combination With Low-Dose Dexamethasone Versus High-Dose Dexamethasone in Subjects With Refractory Multiple Myeloma or Relapsed and Refractory Multiple Myeloma and Companion Study

NCT01311687

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • Mayo Clinic Rochester, Minnesota, United States
  • Royal Adelaide Hospital Adelaide, South Australia, Australia
  • Peter MacCallum Cancer Institute East Melbourne, Victoria, Australia
  • Frankston Hospital Frankston, Victoria, Australia
View all 94 locations
View Trial Details

Related conditions